Global Biomaterial Implants

Biomaterial Implants Comprehensive Study by Type (Cardiovascular, Dental, Orthopedic, Wound Healing, Plastic Surgery, Ophthalmology, Tissue Engineering, Neurological Disorders, Drug-Delivery Systems), Application (Hospital, Clinic, Beauty Institutions), Materials (Metallic, Polymeric, Ceramic, Natural, Others), End-User (Adult, Pediatric) Players and Region - Global Market Outlook to 2026

Biomaterial Implants Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Biomaterial Implants Market Scope?
Biomaterials are artificially derived synthetic or natural materials that are utilized in medical technology to enhance the functionality of broken tissues and organs. These biomaterials are used to move with biological systems for medical functions and coverings of the vessel, dental, orthopedic, and neurologic disorders. Moreover, biomaterials science is often enforced in numerous advanced medical technologies such, tissue engineering, cosmetic surgery, drug delivery devices, and alternative medical implants. Biomaterial applications are finding prominence within the research on Biomed engineering, biomineralization, and biomolecules. A rise in geriatric population, high prevalence of vessel, neurologic, & medical science disorders, and serious funding by government organizations to launch new products, increase awareness concerning the benefits of biomaterials product, increase production of implantable products, and advancements in medical technology are the key drivers of the market. The expansion of the market is hindered by factors, like the high price of biomaterial production, the incidence of inflammatory responses due to compatibility problems, and complications related to the utilization of these products.

The Biomaterial Implants market study is being classified by Type (Cardiovascular, Dental, Orthopedic, Wound Healing, Plastic Surgery, Ophthalmology, Tissue Engineering, Neurological Disorders and Drug-Delivery Systems), by Application (Hospital, Clinic and Beauty Institutions) and major geographies with country level break-up.

The market for implants is on rising due to the rise in the population of geriatrics. The increased research and development in this field of healthcare are increasing the market size and also the heavy investment by the government in this field is helping the market to grow. Research Analyst at AMA predicts that Players from European will contribute to the maximum growth of Global Biomaterial Implants market throughout the predicted period.

Royal DSM (Netherlands), Wright Medical Technology, Inc (United States), Corbion N.V. (Netherlands), Zimmer Biomet Holdings, Inc. (United States), Bayer AG (Germany), Evonik Industries AG (Germany), BASF SE (Germany), Invibio Ltd. (United Kingdom) and Collagen Matrix. (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Carpenter Technology Corporation (United States).

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Biomaterial Implants market by Type, Application and Region.

On the basis of geography, the market of Biomaterial Implants has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).




Influencing Market Trend
  • Increasing Trend of Healthcare Expenditure

Market Drivers
  • Increase in Geriatric Population
  • High Prevalence of Cardiovascular, Neurological, and Orthopaedic Disorders

Opportunities
  • Heavy Funding from The Government Organizations to Launch New Products
  • Increased Production of Implantable Products

Restraints
  • High Cost of Biomaterial Production
  • Occurrence of Inflammatory Responses

Challenges
  • Severe Complications Associated with The Use of Compatibility Issues


Key Target Audience
Manufacturers of Biomaterial Implants, Suppliers and distributors of Biomaterial Implants, Governmental and Regulatory bodies, End-Users and Potential Investors

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research & Media features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Report Objectives / Segmentation Covered

By Type
  • Cardiovascular
  • Dental
  • Orthopedic
  • Wound Healing
  • Plastic Surgery
  • Ophthalmology
  • Tissue Engineering
  • Neurological Disorders
  • Drug-Delivery Systems
By Application
  • Hospital
  • Clinic
  • Beauty Institutions
By Materials
  • Metallic
  • Polymeric
  • Ceramic
  • Natural
  • Others

By End-User
  • Adult
  • Pediatric

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase in Geriatric Population
      • 3.2.2. High Prevalence of Cardiovascular, Neurological, and Orthopaedic Disorders
    • 3.3. Market Challenges
      • 3.3.1. Severe Complications Associated with The Use of Compatibility Issues
    • 3.4. Market Trends
      • 3.4.1. Increasing Trend of Healthcare Expenditure
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Biomaterial Implants, by Type, Application, Materials, End-User and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Biomaterial Implants (Value)
      • 5.2.1. Global Biomaterial Implants by: Type (Value)
        • 5.2.1.1. Cardiovascular
        • 5.2.1.2. Dental
        • 5.2.1.3. Orthopedic
        • 5.2.1.4. Wound Healing
        • 5.2.1.5. Plastic Surgery
        • 5.2.1.6. Ophthalmology
        • 5.2.1.7. Tissue Engineering
        • 5.2.1.8. Neurological Disorders
        • 5.2.1.9. Drug-Delivery Systems
      • 5.2.2. Global Biomaterial Implants by: Application (Value)
        • 5.2.2.1. Hospital
        • 5.2.2.2. Clinic
        • 5.2.2.3. Beauty Institutions
      • 5.2.3. Global Biomaterial Implants by: Materials (Value)
        • 5.2.3.1. Metallic
        • 5.2.3.2. Polymeric
        • 5.2.3.3. Ceramic
        • 5.2.3.4. Natural
        • 5.2.3.5. Others
      • 5.2.4. Global Biomaterial Implants by: End-User (Value)
        • 5.2.4.1. Adult
        • 5.2.4.2. Pediatric
      • 5.2.5. Global Biomaterial Implants Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Biomaterial Implants (Price)
      • 5.3.1. Global Biomaterial Implants by: Type (Price)
  • 6. Biomaterial Implants: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Royal DSM (Netherlands)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Wright Medical Technology, Inc (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Corbion N.V. (Netherlands)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Zimmer Biomet Holdings, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Bayer AG (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Evonik Industries AG (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. BASF SE (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Invibio Ltd. (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Collagen Matrix. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Biomaterial Implants Sale, by Type, Application, Materials, End-User and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Biomaterial Implants (Value)
      • 7.2.1. Global Biomaterial Implants by: Type (Value)
        • 7.2.1.1. Cardiovascular
        • 7.2.1.2. Dental
        • 7.2.1.3. Orthopedic
        • 7.2.1.4. Wound Healing
        • 7.2.1.5. Plastic Surgery
        • 7.2.1.6. Ophthalmology
        • 7.2.1.7. Tissue Engineering
        • 7.2.1.8. Neurological Disorders
        • 7.2.1.9. Drug-Delivery Systems
      • 7.2.2. Global Biomaterial Implants by: Application (Value)
        • 7.2.2.1. Hospital
        • 7.2.2.2. Clinic
        • 7.2.2.3. Beauty Institutions
      • 7.2.3. Global Biomaterial Implants by: Materials (Value)
        • 7.2.3.1. Metallic
        • 7.2.3.2. Polymeric
        • 7.2.3.3. Ceramic
        • 7.2.3.4. Natural
        • 7.2.3.5. Others
      • 7.2.4. Global Biomaterial Implants by: End-User (Value)
        • 7.2.4.1. Adult
        • 7.2.4.2. Pediatric
      • 7.2.5. Global Biomaterial Implants Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Biomaterial Implants (Price)
      • 7.3.1. Global Biomaterial Implants by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Biomaterial Implants: by Type(USD Million)
  • Table 2. Biomaterial Implants Cardiovascular , by Region USD Million (2015-2020)
  • Table 3. Biomaterial Implants Dental , by Region USD Million (2015-2020)
  • Table 4. Biomaterial Implants Orthopedic , by Region USD Million (2015-2020)
  • Table 5. Biomaterial Implants Wound Healing , by Region USD Million (2015-2020)
  • Table 6. Biomaterial Implants Plastic Surgery , by Region USD Million (2015-2020)
  • Table 7. Biomaterial Implants Ophthalmology , by Region USD Million (2015-2020)
  • Table 8. Biomaterial Implants Tissue Engineering , by Region USD Million (2015-2020)
  • Table 9. Biomaterial Implants Neurological Disorders , by Region USD Million (2015-2020)
  • Table 10. Biomaterial Implants Drug-Delivery Systems , by Region USD Million (2015-2020)
  • Table 11. Biomaterial Implants: by Application(USD Million)
  • Table 12. Biomaterial Implants Hospital , by Region USD Million (2015-2020)
  • Table 13. Biomaterial Implants Clinic , by Region USD Million (2015-2020)
  • Table 14. Biomaterial Implants Beauty Institutions , by Region USD Million (2015-2020)
  • Table 15. Biomaterial Implants: by Materials(USD Million)
  • Table 16. Biomaterial Implants Metallic , by Region USD Million (2015-2020)
  • Table 17. Biomaterial Implants Polymeric , by Region USD Million (2015-2020)
  • Table 18. Biomaterial Implants Ceramic , by Region USD Million (2015-2020)
  • Table 19. Biomaterial Implants Natural , by Region USD Million (2015-2020)
  • Table 20. Biomaterial Implants Others , by Region USD Million (2015-2020)
  • Table 21. Biomaterial Implants: by End-User(USD Million)
  • Table 22. Biomaterial Implants Adult , by Region USD Million (2015-2020)
  • Table 23. Biomaterial Implants Pediatric , by Region USD Million (2015-2020)
  • Table 24. South America Biomaterial Implants, by Country USD Million (2015-2020)
  • Table 25. South America Biomaterial Implants, by Type USD Million (2015-2020)
  • Table 26. South America Biomaterial Implants, by Application USD Million (2015-2020)
  • Table 27. South America Biomaterial Implants, by Materials USD Million (2015-2020)
  • Table 28. South America Biomaterial Implants, by End-User USD Million (2015-2020)
  • Table 29. Brazil Biomaterial Implants, by Type USD Million (2015-2020)
  • Table 30. Brazil Biomaterial Implants, by Application USD Million (2015-2020)
  • Table 31. Brazil Biomaterial Implants, by Materials USD Million (2015-2020)
  • Table 32. Brazil Biomaterial Implants, by End-User USD Million (2015-2020)
  • Table 33. Argentina Biomaterial Implants, by Type USD Million (2015-2020)
  • Table 34. Argentina Biomaterial Implants, by Application USD Million (2015-2020)
  • Table 35. Argentina Biomaterial Implants, by Materials USD Million (2015-2020)
  • Table 36. Argentina Biomaterial Implants, by End-User USD Million (2015-2020)
  • Table 37. Rest of South America Biomaterial Implants, by Type USD Million (2015-2020)
  • Table 38. Rest of South America Biomaterial Implants, by Application USD Million (2015-2020)
  • Table 39. Rest of South America Biomaterial Implants, by Materials USD Million (2015-2020)
  • Table 40. Rest of South America Biomaterial Implants, by End-User USD Million (2015-2020)
  • Table 41. Asia Pacific Biomaterial Implants, by Country USD Million (2015-2020)
  • Table 42. Asia Pacific Biomaterial Implants, by Type USD Million (2015-2020)
  • Table 43. Asia Pacific Biomaterial Implants, by Application USD Million (2015-2020)
  • Table 44. Asia Pacific Biomaterial Implants, by Materials USD Million (2015-2020)
  • Table 45. Asia Pacific Biomaterial Implants, by End-User USD Million (2015-2020)
  • Table 46. China Biomaterial Implants, by Type USD Million (2015-2020)
  • Table 47. China Biomaterial Implants, by Application USD Million (2015-2020)
  • Table 48. China Biomaterial Implants, by Materials USD Million (2015-2020)
  • Table 49. China Biomaterial Implants, by End-User USD Million (2015-2020)
  • Table 50. Japan Biomaterial Implants, by Type USD Million (2015-2020)
  • Table 51. Japan Biomaterial Implants, by Application USD Million (2015-2020)
  • Table 52. Japan Biomaterial Implants, by Materials USD Million (2015-2020)
  • Table 53. Japan Biomaterial Implants, by End-User USD Million (2015-2020)
  • Table 54. India Biomaterial Implants, by Type USD Million (2015-2020)
  • Table 55. India Biomaterial Implants, by Application USD Million (2015-2020)
  • Table 56. India Biomaterial Implants, by Materials USD Million (2015-2020)
  • Table 57. India Biomaterial Implants, by End-User USD Million (2015-2020)
  • Table 58. South Korea Biomaterial Implants, by Type USD Million (2015-2020)
  • Table 59. South Korea Biomaterial Implants, by Application USD Million (2015-2020)
  • Table 60. South Korea Biomaterial Implants, by Materials USD Million (2015-2020)
  • Table 61. South Korea Biomaterial Implants, by End-User USD Million (2015-2020)
  • Table 62. Taiwan Biomaterial Implants, by Type USD Million (2015-2020)
  • Table 63. Taiwan Biomaterial Implants, by Application USD Million (2015-2020)
  • Table 64. Taiwan Biomaterial Implants, by Materials USD Million (2015-2020)
  • Table 65. Taiwan Biomaterial Implants, by End-User USD Million (2015-2020)
  • Table 66. Australia Biomaterial Implants, by Type USD Million (2015-2020)
  • Table 67. Australia Biomaterial Implants, by Application USD Million (2015-2020)
  • Table 68. Australia Biomaterial Implants, by Materials USD Million (2015-2020)
  • Table 69. Australia Biomaterial Implants, by End-User USD Million (2015-2020)
  • Table 70. Rest of Asia-Pacific Biomaterial Implants, by Type USD Million (2015-2020)
  • Table 71. Rest of Asia-Pacific Biomaterial Implants, by Application USD Million (2015-2020)
  • Table 72. Rest of Asia-Pacific Biomaterial Implants, by Materials USD Million (2015-2020)
  • Table 73. Rest of Asia-Pacific Biomaterial Implants, by End-User USD Million (2015-2020)
  • Table 74. Europe Biomaterial Implants, by Country USD Million (2015-2020)
  • Table 75. Europe Biomaterial Implants, by Type USD Million (2015-2020)
  • Table 76. Europe Biomaterial Implants, by Application USD Million (2015-2020)
  • Table 77. Europe Biomaterial Implants, by Materials USD Million (2015-2020)
  • Table 78. Europe Biomaterial Implants, by End-User USD Million (2015-2020)
  • Table 79. Germany Biomaterial Implants, by Type USD Million (2015-2020)
  • Table 80. Germany Biomaterial Implants, by Application USD Million (2015-2020)
  • Table 81. Germany Biomaterial Implants, by Materials USD Million (2015-2020)
  • Table 82. Germany Biomaterial Implants, by End-User USD Million (2015-2020)
  • Table 83. France Biomaterial Implants, by Type USD Million (2015-2020)
  • Table 84. France Biomaterial Implants, by Application USD Million (2015-2020)
  • Table 85. France Biomaterial Implants, by Materials USD Million (2015-2020)
  • Table 86. France Biomaterial Implants, by End-User USD Million (2015-2020)
  • Table 87. Italy Biomaterial Implants, by Type USD Million (2015-2020)
  • Table 88. Italy Biomaterial Implants, by Application USD Million (2015-2020)
  • Table 89. Italy Biomaterial Implants, by Materials USD Million (2015-2020)
  • Table 90. Italy Biomaterial Implants, by End-User USD Million (2015-2020)
  • Table 91. United Kingdom Biomaterial Implants, by Type USD Million (2015-2020)
  • Table 92. United Kingdom Biomaterial Implants, by Application USD Million (2015-2020)
  • Table 93. United Kingdom Biomaterial Implants, by Materials USD Million (2015-2020)
  • Table 94. United Kingdom Biomaterial Implants, by End-User USD Million (2015-2020)
  • Table 95. Netherlands Biomaterial Implants, by Type USD Million (2015-2020)
  • Table 96. Netherlands Biomaterial Implants, by Application USD Million (2015-2020)
  • Table 97. Netherlands Biomaterial Implants, by Materials USD Million (2015-2020)
  • Table 98. Netherlands Biomaterial Implants, by End-User USD Million (2015-2020)
  • Table 99. Rest of Europe Biomaterial Implants, by Type USD Million (2015-2020)
  • Table 100. Rest of Europe Biomaterial Implants, by Application USD Million (2015-2020)
  • Table 101. Rest of Europe Biomaterial Implants, by Materials USD Million (2015-2020)
  • Table 102. Rest of Europe Biomaterial Implants, by End-User USD Million (2015-2020)
  • Table 103. MEA Biomaterial Implants, by Country USD Million (2015-2020)
  • Table 104. MEA Biomaterial Implants, by Type USD Million (2015-2020)
  • Table 105. MEA Biomaterial Implants, by Application USD Million (2015-2020)
  • Table 106. MEA Biomaterial Implants, by Materials USD Million (2015-2020)
  • Table 107. MEA Biomaterial Implants, by End-User USD Million (2015-2020)
  • Table 108. Middle East Biomaterial Implants, by Type USD Million (2015-2020)
  • Table 109. Middle East Biomaterial Implants, by Application USD Million (2015-2020)
  • Table 110. Middle East Biomaterial Implants, by Materials USD Million (2015-2020)
  • Table 111. Middle East Biomaterial Implants, by End-User USD Million (2015-2020)
  • Table 112. Africa Biomaterial Implants, by Type USD Million (2015-2020)
  • Table 113. Africa Biomaterial Implants, by Application USD Million (2015-2020)
  • Table 114. Africa Biomaterial Implants, by Materials USD Million (2015-2020)
  • Table 115. Africa Biomaterial Implants, by End-User USD Million (2015-2020)
  • Table 116. North America Biomaterial Implants, by Country USD Million (2015-2020)
  • Table 117. North America Biomaterial Implants, by Type USD Million (2015-2020)
  • Table 118. North America Biomaterial Implants, by Application USD Million (2015-2020)
  • Table 119. North America Biomaterial Implants, by Materials USD Million (2015-2020)
  • Table 120. North America Biomaterial Implants, by End-User USD Million (2015-2020)
  • Table 121. United States Biomaterial Implants, by Type USD Million (2015-2020)
  • Table 122. United States Biomaterial Implants, by Application USD Million (2015-2020)
  • Table 123. United States Biomaterial Implants, by Materials USD Million (2015-2020)
  • Table 124. United States Biomaterial Implants, by End-User USD Million (2015-2020)
  • Table 125. Canada Biomaterial Implants, by Type USD Million (2015-2020)
  • Table 126. Canada Biomaterial Implants, by Application USD Million (2015-2020)
  • Table 127. Canada Biomaterial Implants, by Materials USD Million (2015-2020)
  • Table 128. Canada Biomaterial Implants, by End-User USD Million (2015-2020)
  • Table 129. Mexico Biomaterial Implants, by Type USD Million (2015-2020)
  • Table 130. Mexico Biomaterial Implants, by Application USD Million (2015-2020)
  • Table 131. Mexico Biomaterial Implants, by Materials USD Million (2015-2020)
  • Table 132. Mexico Biomaterial Implants, by End-User USD Million (2015-2020)
  • Table 133. Biomaterial Implants: by Type(USD/Units)
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Biomaterial Implants: by Type(USD Million)
  • Table 144. Biomaterial Implants Cardiovascular , by Region USD Million (2021-2026)
  • Table 145. Biomaterial Implants Dental , by Region USD Million (2021-2026)
  • Table 146. Biomaterial Implants Orthopedic , by Region USD Million (2021-2026)
  • Table 147. Biomaterial Implants Wound Healing , by Region USD Million (2021-2026)
  • Table 148. Biomaterial Implants Plastic Surgery , by Region USD Million (2021-2026)
  • Table 149. Biomaterial Implants Ophthalmology , by Region USD Million (2021-2026)
  • Table 150. Biomaterial Implants Tissue Engineering , by Region USD Million (2021-2026)
  • Table 151. Biomaterial Implants Neurological Disorders , by Region USD Million (2021-2026)
  • Table 152. Biomaterial Implants Drug-Delivery Systems , by Region USD Million (2021-2026)
  • Table 153. Biomaterial Implants: by Application(USD Million)
  • Table 154. Biomaterial Implants Hospital , by Region USD Million (2021-2026)
  • Table 155. Biomaterial Implants Clinic , by Region USD Million (2021-2026)
  • Table 156. Biomaterial Implants Beauty Institutions , by Region USD Million (2021-2026)
  • Table 157. Biomaterial Implants: by Materials(USD Million)
  • Table 158. Biomaterial Implants Metallic , by Region USD Million (2021-2026)
  • Table 159. Biomaterial Implants Polymeric , by Region USD Million (2021-2026)
  • Table 160. Biomaterial Implants Ceramic , by Region USD Million (2021-2026)
  • Table 161. Biomaterial Implants Natural , by Region USD Million (2021-2026)
  • Table 162. Biomaterial Implants Others , by Region USD Million (2021-2026)
  • Table 163. Biomaterial Implants: by End-User(USD Million)
  • Table 164. Biomaterial Implants Adult , by Region USD Million (2021-2026)
  • Table 165. Biomaterial Implants Pediatric , by Region USD Million (2021-2026)
  • Table 166. South America Biomaterial Implants, by Country USD Million (2021-2026)
  • Table 167. South America Biomaterial Implants, by Type USD Million (2021-2026)
  • Table 168. South America Biomaterial Implants, by Application USD Million (2021-2026)
  • Table 169. South America Biomaterial Implants, by Materials USD Million (2021-2026)
  • Table 170. South America Biomaterial Implants, by End-User USD Million (2021-2026)
  • Table 171. Brazil Biomaterial Implants, by Type USD Million (2021-2026)
  • Table 172. Brazil Biomaterial Implants, by Application USD Million (2021-2026)
  • Table 173. Brazil Biomaterial Implants, by Materials USD Million (2021-2026)
  • Table 174. Brazil Biomaterial Implants, by End-User USD Million (2021-2026)
  • Table 175. Argentina Biomaterial Implants, by Type USD Million (2021-2026)
  • Table 176. Argentina Biomaterial Implants, by Application USD Million (2021-2026)
  • Table 177. Argentina Biomaterial Implants, by Materials USD Million (2021-2026)
  • Table 178. Argentina Biomaterial Implants, by End-User USD Million (2021-2026)
  • Table 179. Rest of South America Biomaterial Implants, by Type USD Million (2021-2026)
  • Table 180. Rest of South America Biomaterial Implants, by Application USD Million (2021-2026)
  • Table 181. Rest of South America Biomaterial Implants, by Materials USD Million (2021-2026)
  • Table 182. Rest of South America Biomaterial Implants, by End-User USD Million (2021-2026)
  • Table 183. Asia Pacific Biomaterial Implants, by Country USD Million (2021-2026)
  • Table 184. Asia Pacific Biomaterial Implants, by Type USD Million (2021-2026)
  • Table 185. Asia Pacific Biomaterial Implants, by Application USD Million (2021-2026)
  • Table 186. Asia Pacific Biomaterial Implants, by Materials USD Million (2021-2026)
  • Table 187. Asia Pacific Biomaterial Implants, by End-User USD Million (2021-2026)
  • Table 188. China Biomaterial Implants, by Type USD Million (2021-2026)
  • Table 189. China Biomaterial Implants, by Application USD Million (2021-2026)
  • Table 190. China Biomaterial Implants, by Materials USD Million (2021-2026)
  • Table 191. China Biomaterial Implants, by End-User USD Million (2021-2026)
  • Table 192. Japan Biomaterial Implants, by Type USD Million (2021-2026)
  • Table 193. Japan Biomaterial Implants, by Application USD Million (2021-2026)
  • Table 194. Japan Biomaterial Implants, by Materials USD Million (2021-2026)
  • Table 195. Japan Biomaterial Implants, by End-User USD Million (2021-2026)
  • Table 196. India Biomaterial Implants, by Type USD Million (2021-2026)
  • Table 197. India Biomaterial Implants, by Application USD Million (2021-2026)
  • Table 198. India Biomaterial Implants, by Materials USD Million (2021-2026)
  • Table 199. India Biomaterial Implants, by End-User USD Million (2021-2026)
  • Table 200. South Korea Biomaterial Implants, by Type USD Million (2021-2026)
  • Table 201. South Korea Biomaterial Implants, by Application USD Million (2021-2026)
  • Table 202. South Korea Biomaterial Implants, by Materials USD Million (2021-2026)
  • Table 203. South Korea Biomaterial Implants, by End-User USD Million (2021-2026)
  • Table 204. Taiwan Biomaterial Implants, by Type USD Million (2021-2026)
  • Table 205. Taiwan Biomaterial Implants, by Application USD Million (2021-2026)
  • Table 206. Taiwan Biomaterial Implants, by Materials USD Million (2021-2026)
  • Table 207. Taiwan Biomaterial Implants, by End-User USD Million (2021-2026)
  • Table 208. Australia Biomaterial Implants, by Type USD Million (2021-2026)
  • Table 209. Australia Biomaterial Implants, by Application USD Million (2021-2026)
  • Table 210. Australia Biomaterial Implants, by Materials USD Million (2021-2026)
  • Table 211. Australia Biomaterial Implants, by End-User USD Million (2021-2026)
  • Table 212. Rest of Asia-Pacific Biomaterial Implants, by Type USD Million (2021-2026)
  • Table 213. Rest of Asia-Pacific Biomaterial Implants, by Application USD Million (2021-2026)
  • Table 214. Rest of Asia-Pacific Biomaterial Implants, by Materials USD Million (2021-2026)
  • Table 215. Rest of Asia-Pacific Biomaterial Implants, by End-User USD Million (2021-2026)
  • Table 216. Europe Biomaterial Implants, by Country USD Million (2021-2026)
  • Table 217. Europe Biomaterial Implants, by Type USD Million (2021-2026)
  • Table 218. Europe Biomaterial Implants, by Application USD Million (2021-2026)
  • Table 219. Europe Biomaterial Implants, by Materials USD Million (2021-2026)
  • Table 220. Europe Biomaterial Implants, by End-User USD Million (2021-2026)
  • Table 221. Germany Biomaterial Implants, by Type USD Million (2021-2026)
  • Table 222. Germany Biomaterial Implants, by Application USD Million (2021-2026)
  • Table 223. Germany Biomaterial Implants, by Materials USD Million (2021-2026)
  • Table 224. Germany Biomaterial Implants, by End-User USD Million (2021-2026)
  • Table 225. France Biomaterial Implants, by Type USD Million (2021-2026)
  • Table 226. France Biomaterial Implants, by Application USD Million (2021-2026)
  • Table 227. France Biomaterial Implants, by Materials USD Million (2021-2026)
  • Table 228. France Biomaterial Implants, by End-User USD Million (2021-2026)
  • Table 229. Italy Biomaterial Implants, by Type USD Million (2021-2026)
  • Table 230. Italy Biomaterial Implants, by Application USD Million (2021-2026)
  • Table 231. Italy Biomaterial Implants, by Materials USD Million (2021-2026)
  • Table 232. Italy Biomaterial Implants, by End-User USD Million (2021-2026)
  • Table 233. United Kingdom Biomaterial Implants, by Type USD Million (2021-2026)
  • Table 234. United Kingdom Biomaterial Implants, by Application USD Million (2021-2026)
  • Table 235. United Kingdom Biomaterial Implants, by Materials USD Million (2021-2026)
  • Table 236. United Kingdom Biomaterial Implants, by End-User USD Million (2021-2026)
  • Table 237. Netherlands Biomaterial Implants, by Type USD Million (2021-2026)
  • Table 238. Netherlands Biomaterial Implants, by Application USD Million (2021-2026)
  • Table 239. Netherlands Biomaterial Implants, by Materials USD Million (2021-2026)
  • Table 240. Netherlands Biomaterial Implants, by End-User USD Million (2021-2026)
  • Table 241. Rest of Europe Biomaterial Implants, by Type USD Million (2021-2026)
  • Table 242. Rest of Europe Biomaterial Implants, by Application USD Million (2021-2026)
  • Table 243. Rest of Europe Biomaterial Implants, by Materials USD Million (2021-2026)
  • Table 244. Rest of Europe Biomaterial Implants, by End-User USD Million (2021-2026)
  • Table 245. MEA Biomaterial Implants, by Country USD Million (2021-2026)
  • Table 246. MEA Biomaterial Implants, by Type USD Million (2021-2026)
  • Table 247. MEA Biomaterial Implants, by Application USD Million (2021-2026)
  • Table 248. MEA Biomaterial Implants, by Materials USD Million (2021-2026)
  • Table 249. MEA Biomaterial Implants, by End-User USD Million (2021-2026)
  • Table 250. Middle East Biomaterial Implants, by Type USD Million (2021-2026)
  • Table 251. Middle East Biomaterial Implants, by Application USD Million (2021-2026)
  • Table 252. Middle East Biomaterial Implants, by Materials USD Million (2021-2026)
  • Table 253. Middle East Biomaterial Implants, by End-User USD Million (2021-2026)
  • Table 254. Africa Biomaterial Implants, by Type USD Million (2021-2026)
  • Table 255. Africa Biomaterial Implants, by Application USD Million (2021-2026)
  • Table 256. Africa Biomaterial Implants, by Materials USD Million (2021-2026)
  • Table 257. Africa Biomaterial Implants, by End-User USD Million (2021-2026)
  • Table 258. North America Biomaterial Implants, by Country USD Million (2021-2026)
  • Table 259. North America Biomaterial Implants, by Type USD Million (2021-2026)
  • Table 260. North America Biomaterial Implants, by Application USD Million (2021-2026)
  • Table 261. North America Biomaterial Implants, by Materials USD Million (2021-2026)
  • Table 262. North America Biomaterial Implants, by End-User USD Million (2021-2026)
  • Table 263. United States Biomaterial Implants, by Type USD Million (2021-2026)
  • Table 264. United States Biomaterial Implants, by Application USD Million (2021-2026)
  • Table 265. United States Biomaterial Implants, by Materials USD Million (2021-2026)
  • Table 266. United States Biomaterial Implants, by End-User USD Million (2021-2026)
  • Table 267. Canada Biomaterial Implants, by Type USD Million (2021-2026)
  • Table 268. Canada Biomaterial Implants, by Application USD Million (2021-2026)
  • Table 269. Canada Biomaterial Implants, by Materials USD Million (2021-2026)
  • Table 270. Canada Biomaterial Implants, by End-User USD Million (2021-2026)
  • Table 271. Mexico Biomaterial Implants, by Type USD Million (2021-2026)
  • Table 272. Mexico Biomaterial Implants, by Application USD Million (2021-2026)
  • Table 273. Mexico Biomaterial Implants, by Materials USD Million (2021-2026)
  • Table 274. Mexico Biomaterial Implants, by End-User USD Million (2021-2026)
  • Table 275. Biomaterial Implants: by Type(USD/Units)
  • Table 276. Research Programs/Design for This Report
  • Table 277. Key Data Information from Secondary Sources
  • Table 278. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Biomaterial Implants: by Type USD Million (2015-2020)
  • Figure 5. Global Biomaterial Implants: by Application USD Million (2015-2020)
  • Figure 6. Global Biomaterial Implants: by Materials USD Million (2015-2020)
  • Figure 7. Global Biomaterial Implants: by End-User USD Million (2015-2020)
  • Figure 8. South America Biomaterial Implants Share (%), by Country
  • Figure 9. Asia Pacific Biomaterial Implants Share (%), by Country
  • Figure 10. Europe Biomaterial Implants Share (%), by Country
  • Figure 11. MEA Biomaterial Implants Share (%), by Country
  • Figure 12. North America Biomaterial Implants Share (%), by Country
  • Figure 13. Global Biomaterial Implants: by Type USD/Units (2015-2020)
  • Figure 14. Global Biomaterial Implants share by Players 2020 (%)
  • Figure 15. Global Biomaterial Implants share by Players (Top 3) 2020(%)
  • Figure 16. Global Biomaterial Implants share by Players (Top 5) 2020(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Royal DSM (Netherlands) Revenue, Net Income and Gross profit
  • Figure 19. Royal DSM (Netherlands) Revenue: by Geography 2020
  • Figure 20. Wright Medical Technology, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 21. Wright Medical Technology, Inc (United States) Revenue: by Geography 2020
  • Figure 22. Corbion N.V. (Netherlands) Revenue, Net Income and Gross profit
  • Figure 23. Corbion N.V. (Netherlands) Revenue: by Geography 2020
  • Figure 24. Zimmer Biomet Holdings, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 25. Zimmer Biomet Holdings, Inc. (United States) Revenue: by Geography 2020
  • Figure 26. Bayer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 27. Bayer AG (Germany) Revenue: by Geography 2020
  • Figure 28. Evonik Industries AG (Germany) Revenue, Net Income and Gross profit
  • Figure 29. Evonik Industries AG (Germany) Revenue: by Geography 2020
  • Figure 30. BASF SE (Germany) Revenue, Net Income and Gross profit
  • Figure 31. BASF SE (Germany) Revenue: by Geography 2020
  • Figure 32. Invibio Ltd. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 33. Invibio Ltd. (United Kingdom) Revenue: by Geography 2020
  • Figure 34. Collagen Matrix. (United States) Revenue, Net Income and Gross profit
  • Figure 35. Collagen Matrix. (United States) Revenue: by Geography 2020
  • Figure 36. Global Biomaterial Implants: by Type USD Million (2021-2026)
  • Figure 37. Global Biomaterial Implants: by Application USD Million (2021-2026)
  • Figure 38. Global Biomaterial Implants: by Materials USD Million (2021-2026)
  • Figure 39. Global Biomaterial Implants: by End-User USD Million (2021-2026)
  • Figure 40. South America Biomaterial Implants Share (%), by Country
  • Figure 41. Asia Pacific Biomaterial Implants Share (%), by Country
  • Figure 42. Europe Biomaterial Implants Share (%), by Country
  • Figure 43. MEA Biomaterial Implants Share (%), by Country
  • Figure 44. North America Biomaterial Implants Share (%), by Country
  • Figure 45. Global Biomaterial Implants: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Royal DSM (Netherlands)
  • Wright Medical Technology, Inc (United States)
  • Corbion N.V. (Netherlands)
  • Zimmer Biomet Holdings, Inc. (United States)
  • Bayer AG (Germany)
  • Evonik Industries AG (Germany)
  • BASF SE (Germany)
  • Invibio Ltd. (United Kingdom)
  • Collagen Matrix. (United States)
Additional players considered in the study are as follows:
Carpenter Technology Corporation (United States)
Select User Access Type

Key Highlights of Report


May 2021 240 Pages 58 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Biomaterial Implants Quantitative research analysis
Global Biomaterial Implants Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global Biomaterial Implants Report?

Have a Query? Click Here

Other Related Reports

Critical Care Services Comprehensive Study by Application (Intensive Care Units, Neonatal Intensive Care Units, Pediatric Intensive Care Units, Coronary Care Units), Critical care equipment (Ventilat...
$ 3750
Bioanalytical Testing Services Comprehensive Study by Type (Cell Based Assays (Bacterial, Viral), Virology Testing (In-Vitro Assays, In-Vivo Assays, Species-Specific Viral PCR Assays), Serology, Immu...
$ 3750
Cerebrospinal Fluid Management Comprehensive Study by Application (Meningitis, Encephalitis, Neurosyphilis, Subarachnoid haemorrhage, Multiple sclerosis, Guillain-Barré syndrome, Meningeal carcinoma...
$ 3750
Neuroendoscopy Comprehensive Study by Type (Rigid Neuroendoscopes, Flexible Neuroendoscopes), Application (Transnasal, Intraventricular, Transcranial), Usability (Reusable, Disposable), End User (Hos...
$ 3650
Medical Automation Comprehensive Study by Type (Diagnostics & Monitoring, Medical Logistics & Training, Lab & Pharmacy Automation, Therapeutics), Medical Logistics & Training Automation (Logistics Au...
$ 3750
Medical Transport Services Comprehensive Study by Type (Medical Products, Incubator Transport, Mobile Treatment Facilities, Patient Transport), Application (Hospitals, Private Paying Customers, Nursi...
$ 3350